NCT06598176View on ClinicalTrials.gov

Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2037

Conditions
Uterine Cervical NeoplasmUterine Cervical DysplasiaHuman Papilloma VirusHPV-Related Cervical Carcinoma
Interventions
DEVICE

Colli-Pee 20mL device with UCM

Women will collect a first-void urine (the initial part of the urine stream) sample at home the day before a hospital appointment using the 20mL Colli-Pee device prefilled with urine conservation medium (UCM, Novosanis, Belgium).

DEVICE

Evalyn Brush

Women will collect a vaginal self-sample using the Evalyn Brush (Rovers Medical Devices, The Netherlands) at home the day before a hospital appointment.

Trial Locations (1)

2650

RECRUITING

Universitair Ziekenhuis Antwerpen (UZA), Edegem

All Listed Sponsors
collaborator

University Hospital, Antwerp

OTHER

lead

Universiteit Antwerpen

OTHER